Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (964)
Prelude Therapeutics Inc (PRLD)
ORBIMED ADVISORS LLC — Director
Shares
1,689,189
Price
$4.44
Total Value
$7.50M
Shares Held After
11,808,945
% of Holdings
14.3%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,850
Price
$70.91
Total Value
$202.09K
Shares Held After
394,070
% of Holdings
0.7%
SANGAMO THERAPEUTICS, INC (SGMO)
Dubois-Stringfellow Nathalie — SVP-CHIEF DEVELOPMENT OFFICER
Shares
345,942
Price
$0.26
Total Value
$89.18K
Shares Held After
332,769
% of Holdings
51.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
8,300
Price
$20.01
Total Value
$166.12K
Shares Held After
4,199,225
% of Holdings
0.2%
Allogene Therapeutics, Inc. (ALLO)
Yoshiyama Annie — SVP, Finance
Shares
9,586
Price
$2.31
Total Value
$22.14K
Shares Held After
124,517
% of Holdings
7.1%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
72,912
Price
$0.33
Total Value
$24.06K
Shares Held After
133,574
% of Holdings
54.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
605
Price
$20.05
Total Value
$12.13K
Shares Held After
1,345,367
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
15
Price
$20.05
Total Value
$300.75
Shares Held After
13,148
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,530
Price
$20.05
Total Value
$30.68K
Shares Held After
5,411,121
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
769
Price
$20.05
Total Value
$15.42K
Shares Held After
1,814,483
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
56,228
Price
$19.51
Total Value
$1.10M
Shares Held After
1,345,972
% of Holdings
4.0%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,398
Price
$19.51
Total Value
$27.27K
Shares Held After
13,163
% of Holdings
9.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
142,253
Price
$19.51
Total Value
$2.78M
Shares Held After
5,412,651
% of Holdings
2.6%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
71,499
Price
$19.51
Total Value
$1.39M
Shares Held After
1,815,252
% of Holdings
3.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
61,345
Price
$6.14
Total Value
$376.66K
Shares Held After
297,066
% of Holdings
17.1%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
400
Price
$1.23
Total Value
$492.00
Shares Held After
275,766
% of Holdings
0.1%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
37,381
Price
$0.99
Total Value
$37.19K
Shares Held After
1,732,582
% of Holdings
2.1%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
9,200
Price
$23.00
Total Value
$211.61K
Shares Held After
145,355
% of Holdings
6.0%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
83,712
Price
$0.99
Total Value
$83.29K
Shares Held After
3,692,423
% of Holdings
2.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
214
Price
$167.34
Total Value
$35.81K
Shares Held After
11,666
% of Holdings
1.8%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
312
Price
$166.49
Total Value
$51.94K
Shares Held After
11,880
% of Holdings
2.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
332
Price
$165.49
Total Value
$54.94K
Shares Held After
12,192
% of Holdings
2.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
78
Price
$164.60
Total Value
$12.84K
Shares Held After
12,524
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
64
Price
$163.49
Total Value
$10.46K
Shares Held After
12,602
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
663
Price
$575.72
Total Value
$381.70K
Shares Held After
40,513
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
701
Price
$574.91
Total Value
$403.01K
Shares Held After
41,176
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,366
Price
$573.48
Total Value
$783.37K
Shares Held After
41,877
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$572.48
Total Value
$234.72K
Shares Held After
43,243
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$571.64
Total Value
$694.54K
Shares Held After
43,653
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
945
Price
$570.65
Total Value
$539.26K
Shares Held After
44,868
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$569.71
Total Value
$387.40K
Shares Held After
45,813
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
269
Price
$568.21
Total Value
$152.85K
Shares Held After
46,493
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,206
Price
$567.54
Total Value
$684.45K
Shares Held After
46,762
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,347
Price
$566.56
Total Value
$763.16K
Shares Held After
47,968
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
539
Price
$565.51
Total Value
$304.81K
Shares Held After
49,315
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
159
Price
$564.35
Total Value
$89.73K
Shares Held After
49,854
% of Holdings
0.3%
Karyopharm Therapeutics Inc. (KPTI)
Rangwala Reshma — EVP & Chief Medical Officer
Shares
449
Price
$8.94
Total Value
$4.01K
Shares Held After
56,290
% of Holdings
0.8%
Onconetix, Inc. (ONCO)
HRT FINANCIAL LP — 10% Owner
Shares
49,710
Price
$0.69
Total Value
$34.30K
Shares Held After
33,649
% of Holdings
59.6%
MeiraGTx Holdings plc (MGTX)
Giroux Richard — CFO & COO
Shares
56,000
Price
$10.22
Total Value
$572.32K
Shares Held After
971,530
% of Holdings
5.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
30,941
Price
$14.66
Total Value
$453.60K
Shares Held After
395,146
% of Holdings
7.3%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$65.69
Total Value
$229.91K
Shares Held After
153,902
% of Holdings
2.2%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
56,368
Price
$20.06
Total Value
$1.13M
Shares Held After
1,402,200
% of Holdings
3.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
1,401
Price
$20.06
Total Value
$28.10K
Shares Held After
14,561
% of Holdings
8.8%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
142,604
Price
$20.06
Total Value
$2.86M
Shares Held After
5,554,904
% of Holdings
2.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
71,676
Price
$20.06
Total Value
$1.44M
Shares Held After
1,886,751
% of Holdings
3.7%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President & Immunovant CEO
Shares
200,000
Price
$29.59
Total Value
$5.92M
Shares Held After
1,647,546
% of Holdings
10.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
4,318
Price
$6.12
Total Value
$26.43K
Shares Held After
358,411
% of Holdings
1.2%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
600
Price
$1.23
Total Value
$738.00
Shares Held After
275,366
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
37,382
Price
$1.01
Total Value
$37.62K
Shares Held After
1,769,963
% of Holdings
2.1%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
83,712
Price
$1.01
Total Value
$84.25K
Shares Held After
3,776,135
% of Holdings
2.2%
Showing 1–50 of 964 transactions (page 1 of 20)